Endocarditis
📧 Sign up to get email alerts when something new happens for Endocarditis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN) [NA]
This clinical trial update describes the RETAIN study on retention and re-engagement in treatment for opioid use disorder following serious …
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Barts Endocarditis Research Registry
A recruiting clinical trial registry at Queen Mary University of London focused on collecting data on endocarditis, including infective endo…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis. [NA]
This clinical trial update reports completion of a study evaluating early exercise training after heart valve surgery for infective endocard…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: 64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis. [NA]
This completed clinical trial investigates the use of 64Cu-DOTATATE PET-CT imaging for diagnosing infective endocarditis, including acute an…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Clinical and Diagnostic Features of Endocarditis
A clinical trial update from University Hospital of Ferrara notes a study on the clinical and diagnostic features of endocarditis that is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures [Phase 4]
A Phase 4 clinical trial is evaluating whether an oral doxycycline regimen can prevent bacteremia after dental procedures. The study is not …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Accelerated Treatment of Endocarditis [Phase 4]
A Phase 4 clinical trial update for accelerated treatment of endocarditis is currently recruiting at Herlev Hospital.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) [Phase 4]
Phase 4 clinical trial updating postoperative antibiotic duration after surgery for endocarditis related to intravenous drug use (IVDA).
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients [Phase 4]
Phase 4 clinical trial update on a strategy to prevent drug-induced nephrotoxicity in high-risk patients; the study was terminated with resu…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures [Phase 4]
Phase 4 study evaluating an oral amoxicillin-clavulanate regimen to prevent bacteremia after dental procedures has been terminated.
-
FDA approval · 2022-01-25FDA Approved: DAPTOMYCIN IN SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)
FDA approved Daptomycin in Sodium Chloride from Baxter Healthcare Corporation through an Original Application. The approval establishes a sa…
-
FDA approval · 2021-11-18FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved vancomycin hydrochloride as a generic drug under an Original Application from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2021-11-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)
The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved dr…
-
FDA approval · 2019-06-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the vancomycin hydrochloride original application for Slate Run Pharmaceuticals, enabling a generic version of this antibiotic.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Partial Oral Treatment of Endocarditis [Phase 4]
Phase 4 clinical trial update on partial oral treatment for endocarditis; study completed.
-
FDA approval · 2019-02-15FDA Approved: TYZAVAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved TYZAVAN (vancomycin) from Hikma Pharmaceuticals USA Inc. under an Original Application (NDA211962). This marks the brand’s offi…
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: Human Cardiac Mitochondria in Acute Endocarditis and Obesity
This clinical trial update reports on a study involving human cardiac mitochondria in obesity and acute endocarditis, sponsored by Universit…
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis [Phase 2]
Phase 2 trial evaluating dalbavancin versus standard of care for completion of treatment in complicated bacteremia or infective endocarditis…
-
FDA approval · 2018-07-10FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for vancomycin hydrochloride from Mylan Institutional LLC, confirming its use for treating serious infe…
-
CLINICAL_TRIALS research · 2018-05-25Clinical Trial Update: A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
This clinical trial update describes a survey of hospitalizations in cardiology units across Sub-Saharan Africa. The study covers various ca…
-
FDA approval · 2018-04-05FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Nafcillin submitted by Baxter Healthcare Corporation under NDA 050655.
-
FDA approval · 2018-02-21FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (SAMSON MEDICAL TECHNOLOGIES LLC)
The FDA approved Samson Medical Technologies LLC's supplemental application for vancomycin hydrochloride, a generic antibiotic, under an app…
-
FDA approval · 2017-07-14FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for naficillin submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials [Phase 4]
Phase 4 clinical trial evaluating the diagnostic value of 99mTc-Leukoscan scintigraphy for infectious endocarditis on surgical materials.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure [Phase 3]
A Phase 3 population PK study evaluating multiple 10 mg/kg doses of daptomycin (Cubicin) in critically ill patients with bacteremia, endocar…